These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 22043825
21. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production. Levin E, Culibrk B, Gyöngyössy-Issa MI, Weiss S, Scammell K, LeFresne W, Jenkins C, Devine DV. Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169 [Abstract] [Full Text] [Related]
23. The role of bicarbonate in platelet additive solution for apheresis platelet concentrates stored with low residual plasma. Radwanski K, Min K. Transfusion; 2013 Mar; 53(3):591-9. PubMed ID: 22725609 [Abstract] [Full Text] [Related]
27. Storage of platelets in a novel additive solution (M-sol), which is prepared by mixing solutions approved for clinical use that are not especially for platelet storage. Hirayama J, Azuma H, Fujihara M, Homma C, Yamamoto S, Ikeda H. Transfusion; 2007 Jun; 47(6):960-5. PubMed ID: 17524083 [Abstract] [Full Text] [Related]
29. Evaluation of the automated collection and extended storage of apheresis platelets in additive solution. Johnson L, Winter KM, Hartkopf-Theis T, Reid S, Kwok M, Marks DC. Transfusion; 2012 Mar; 52(3):503-9. PubMed ID: 21880041 [Abstract] [Full Text] [Related]
30. Influence of pH on stored human platelets. Dekkers DW, De Cuyper IM, van der Meer PF, Verhoeven AJ, de Korte D. Transfusion; 2007 Oct; 47(10):1889-95. PubMed ID: 17880616 [Abstract] [Full Text] [Related]
31. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light. Wagner SJ, Skripchenko A, Myrup A, Awatefe H, Thompson-Montgomery D, Moroff G, Carmichael P, Lin L. Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001 [Abstract] [Full Text] [Related]
33. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days. Shanwell A, Diedrich B, Falker C, Jansson B, Sandgren P, Sundkvist L, Svensson L, Vesterinen M, Gulliksson H. Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814 [Abstract] [Full Text] [Related]
34. In vitro properties of concentrated canine platelets stored in two additive solutions: a comparative study. Hlavac N, Lasta CS, Dalmolin ML, Lacerda LA, de Korte D, Marcondes NA, Terra SR, Fernandes FB, González FHD. BMC Vet Res; 2017 Nov 15; 13(1):334. PubMed ID: 29141627 [Abstract] [Full Text] [Related]
35. Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions. Lozano M, Galan A, Mazzara R, Corash L, Escolar G. Transfusion; 2007 Apr 15; 47(4):666-71. PubMed ID: 17381625 [Abstract] [Full Text] [Related]
36. Impairment of the hemostatic potential of platelets during storage as evaluated by flow cytometry, thrombin generation, and thrombelastography under conditions promoting formation of coated platelets. Svendsen MS, Rojkjaer R, Kristensen AT, Salado-Jimena JA, Kjalke M, Johansson PI. Transfusion; 2007 Nov 15; 47(11):2057-65. PubMed ID: 17958535 [Abstract] [Full Text] [Related]
37. In vitro variables of apheresis platelets are stably maintained for 7 days with 5% residual plasma in a glucose and bicarbonate salt solution, PAS-5. Radwanski K, Wagner SJ, Skripchenko A, Min K. Transfusion; 2012 Jan 15; 52(1):188-94. PubMed ID: 21790624 [Abstract] [Full Text] [Related]
38. In vitro variables of buffy coat-derived platelet concentrates with residual plasma of down to 10% are stably maintained in new-generation platelet additive solutions. Gravemann U, Volgmann T, Min K, Philipp R, Lambrecht B, Müller TH, Seltsam A. Transfusion; 2015 Jul 15; 55(7):1700-9. PubMed ID: 25677807 [Abstract] [Full Text] [Related]
39. Interruption of agitation of platelet concentrates: effects on in vitro parameters. van der Meer PF, Gulliksson H, Aubuchon JP, Prowse C, Richter E, de Wildt-Eggen J, Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Vox Sang; 2005 May 15; 88(4):227-34. PubMed ID: 15877643 [Abstract] [Full Text] [Related]